This NZX-listed healthcare distributor has gone through a meteoric phase of growth, completing roughly 20 acquisitions over the past 10 years.

Pacific Edge widened its first-half loss, spending more on the roll-out of products across America.

The price for one year of perfect health for a NZ patient turned out to be $35,714 in Pharmac's funding of new medicines in the last financial year.

Researchers have developed a protein-based drug that offers a potential breakthrough treatment for those with severe brain and spinal cord injuries.

Two medical researchers are calling for tighter controls on paracetamol sales after their hospital audit found it is the drug of choice for self-harm, especially among teenage girls.

It was absolutely astounding to see kids were able to play more sports and had less wheezing and coughing.

Tim Groser has a sales job in front of him after the Trans-Pacific Partnership kept the doors open wide to foreign investment in Auckland's red hot housing market.

Most people will be more than aware that, like all public relations campaigns, this one will not reveal the full picture.

FRAN O'SULLIVAN: Geneva has the WTO. Brussels hosts the European Union. Will the Trans-Pacific Partnership put Auckland on the map?

What deals have other countries by signing up to the TPP deal?

OPINION: Trade Minister conceded a few nasty points but his brinksmanship in TPP negotiations allows him to stare down critics, writes Fran O'Sullivan.

Why everyone is lining up to take a shot at Martin Shkreli.

Turing Pharmaceuticals boss causes global outrage after purchasing the rights to AIDS drug and pushing up the price simply to make a profit.

New Zealand scientist Jilly Evans will have you believe it was luck that made her one of the world's leading researchers in the development of therapies for cancer and arthritis.

"Making normal sexuality into a medical problem is an easy PR task with enduring serious consequences for the health of NZ women."

Adherium wants to raise as much as A$35 million from Australian and Kiwi investors to help fund the commercial roll-out of its product and continue research and development.

Should we be dismayed or relieved at the disarray the Trans-Pacific Partnership negotiations are in? Sorry, but on the information to hand it is impossible to say.

An active ingredient in a cream used to treat head lice and scabies has been linked to causing cancer and will be withdrawn from sale in New Zealand.

It's said to cure women's low libido by making sex more pleasurable. But with fears over side-effects, many doctors are sceptical.

New Zealand is heading towards a two-tier health system, and it could get a whole lot worse, writes George Laking.

Peter Dunne was keen to stress that his approval should not be construed as setting a wider precedent. But how can it not be?

A former pharmacist who was found guilty of selling and supplying drugs to clients had his registration cancelled by the Health Practitioner's Disciplinary Tribunal.

Panadeine, Nurofen Plus and other medicines containing codeine should be banned from over-the-counter sales, say top pain medicine experts.

A promising lung cancer drug has been rescued by a new American sponsor after a potentially disastrous finding of "unacceptable toxicity" in some patients.

An ointment used to treat common childhood skin infections is driving the rise of antibiotic-resistant superbugs.

A woman's fertility procedure had to be abandoned because she was taking the wrong medication, owing to a mistake by a pharmacist.

A woman spent five days in hospital recovering from liver problems caused by being given the wrong medicine by a pharmacist.

A pharmacist who stole prescription drugs from his former employer, including erectile dysfunction medication and the morning-after pill, has been deregistered.

Douglas Pharmaceuticals, New Zealand's largest developer and manufacturer of generic pharmaceuticals, is targeting annual revenues of $244 million by 2020.